Lululemon Shares Face Sustained Downturn Amid Growth Concerns

The athleisure sector’s former standout performer is weathering its most challenging period in recent memory. Lululemon’s disappointing quarterly results and repeated guidance reductions have investors questioning whether the yoga apparel specialist can stage a recovery or if its equity decline will continue unabated.

International Expansion Offers Glimmer of Hope

Amid widespread operational challenges, Lululemon’s international division has emerged as a relative bright spot. While comparable sales in North America contracted by 4%, international markets delivered an impressive 15% growth surge. Company leadership has specifically highlighted China’s performance as a “beacon” of the brand’s global expansion strategy. Additional strategic initiatives include a new collaboration with premium grocery chain Erewhon and an expanded partnership with the NHL, representing ongoing efforts to reposition the brand for renewed growth.

Guidance Revision Triggers Market Reaction

The most significant development emerged following September’s second-quarter report, when management substantially downgraded their full-year outlook. The company now anticipates 2025 revenue between $10.85 and $11.0 billion, with earnings per share projected in the $12.77 to $12.97 range. This downward revision primarily stems from increased tariff pressures, which are expected to reduce gross profits by approximately $240 million. Market response was swift and severe, with the stock plummeting more than 13% in after-hours trading.

Should investors sell immediately? Or is it worth buying lululemon athletica?

Analytical Community Divided on Prospects

The investment research community remains deeply divided on Lululemon’s trajectory. Jefferies maintained its “Underperform” rating while slashing its price target to just $120. In stark contrast, BTIG analyst Janine Stichter continues to advocate for purchase, establishing a $303 price objective despite acknowledging product delays and softening North American sales. The broader analytical consensus positions itself cautiously with an average “Hold” recommendation, with price targets clustering between $207 and $245.

Valuation Presents Competing Narratives

From a valuation perspective, Lululemon presents a complex picture. Trading at a price-to-earnings multiple of just 11.1, the stock appears significantly discounted compared to both the luxury sector average of 19.8 and competitor multiples averaging 59.6. This valuation discrepancy raises the fundamental question facing investors: does this represent a compelling buying opportunity for a temporary setback, or does it signal deeper structural issues that could make Lululemon a persistent underperformer?